Our product is meticulously engineered and undergoes rigorous testing, focusing on Compound Muscle Action Potential (CMAP). Single muscle administration demonstrates exceptional contraction suppression and muscle palsy effects. Comparative studies confirm equivalence to Botox, with sustained muscle inhibition at specific doses (5 units/kg).

Clinical Journey: From Concept to Approval

• Clinical Sample Production: Meticulous production to ensure consistent quality.
• CRO Selection: Collaboration with reputable Clinical Research Organizations.
• Regulatory Approval: IND submission, examination, and approval to meet international standards.
• Global Distribution: Securing export permissions and global reach.
• Clinical Trials (Phase I & II): Comprehensive safety and efficacy assessments.
• KGMP License: Adherence to Korean Good Manufacturing Practices.
• Patent Innovation: Securing domestic patents and PCTs for cutting-edge drying processes.

Composition: Quality in Every Vial

• 100 Units of Clostridium Botulinum Toxin Type A (IHS): Delivers powerful muscle contraction inhibition.
• 0.5mg Human Serum Albumin (EP): Enhances stability and bioavailability.
• 0.9mg Sodium Chloride (EP): Ensures isotonicity and optimal formulation.
• Strains Identified with Clostridium Botulinum ATCC 3502: Guarantees consistency and quality.
• Stable Production Process: Achieving more than 99% undiluted solution to ensure potency and effectiveness.

Resistance Management Innovation

By minimizing the stock solution per vial, our product significantly reduces the incidence of resistance, ensuring efficacy and prolonged results.

Transform Your Aesthetic Journey

Experience a groundbreaking solution, rigorously tested and crafted for optimal results. This product stands at the forefront of muscle contraction inhibition, delivering unparalleled performance and quality.